vimarsana.com
Home
Live Updates
Why Is Inhibrx Stock Trading Higher Today? - Inhibrx (NASDAQ:INBX), Sanofi (NASDAQ:SNY) : comparemela.com
Why Is Inhibrx Stock Trading Higher Today? - Inhibrx (NASDAQ:INBX), Sanofi (NASDAQ:SNY)
Sanofi's strategic acquisition of Inhibrx's INBRX-101, a alpha-1 antitrypsin therapy in a registrational trial. Learn about the $2.2B merger details and Inhibrx Biosciences' spin-off. Closing expected in Q2 2024.
Related Keywords
United States ,
American ,
Chiesi Farmaceutici ,
Inhibrx Biosciences Inc New ,
Inhibrx Inc ,
Inhibrx Biosciences Inc ,
New Inhibrx ,
Mark Lappe ,
North American ,
comparemela.com © 2020. All Rights Reserved.